| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 3.78e-08 | 38 | 50 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.13e-05 | 118 | 50 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 1.84e-05 | 3 | 50 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 3.68e-05 | 4 | 50 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 3.68e-05 | 4 | 50 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.54e-04 | 227 | 50 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.70e-04 | 230 | 50 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | channel activity | 3.13e-04 | 525 | 50 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.17e-04 | 526 | 50 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 3.54e-04 | 55 | 50 | 3 | GO:0008146 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.99e-04 | 12 | 50 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.43e-04 | 758 | 50 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO2 KCNH8 SLC37A3 SLC16A14 TRPC5 SLC24A1 ABCA7 RHCE KCNH4 RHD | 5.88e-04 | 1180 | 50 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 6.32e-04 | 15 | 50 | 2 | GO:0034483 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 7.96e-04 | 614 | 50 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 8.45e-04 | 74 | 50 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | transporter activity | ANO2 KCNH8 SLC37A3 SLC16A14 TRPC5 SLC24A1 ABCA7 RHCE KCNH4 RHD | 1.16e-03 | 1289 | 50 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | actin binding | 1.20e-03 | 479 | 50 | 6 | GO:0003779 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.13e-03 | 102 | 50 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.47e-03 | 35 | 50 | 2 | GO:0015020 | |
| GeneOntologyMolecularFunction | deacetylase activity | 4.51e-03 | 40 | 50 | 2 | GO:0019213 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 4.60e-03 | 627 | 50 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.69e-03 | 459 | 50 | 5 | GO:0005216 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 5.97e-06 | 15 | 50 | 3 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.07e-05 | 18 | 50 | 3 | GO:0033275 | |
| GeneOntologyBiologicalProcess | muscle system process | 4.68e-05 | 547 | 50 | 8 | GO:0003012 | |
| GeneOntologyBiologicalProcess | ammonium homeostasis | 8.59e-05 | 6 | 50 | 2 | GO:0097272 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.07e-04 | 38 | 50 | 3 | GO:0008209 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.38e-04 | 1017 | 50 | 10 | GO:0098660 | |
| GeneOntologyBiologicalProcess | protein sulfation | 1.60e-04 | 8 | 50 | 2 | GO:0006477 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 1.60e-04 | 8 | 50 | 2 | GO:0070980 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.60e-04 | 8 | 50 | 2 | GO:0015014 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | ADRB2 SRD5A3 TLR2 BCAT2 RENBP UGT2B28 UGT2B11 ABCA7 MOAP1 HDC NEDD4 | 1.65e-04 | 1253 | 50 | 11 | GO:0044248 |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 2.16e-04 | 357 | 50 | 6 | GO:0009101 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 2.56e-04 | 10 | 50 | 2 | GO:0018879 | |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 3.12e-04 | 11 | 50 | 2 | GO:0030210 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 3.23e-04 | 385 | 50 | 6 | GO:0070372 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.74e-04 | 12 | 50 | 2 | GO:0052697 | |
| GeneOntologyBiologicalProcess | muscle contraction | 3.96e-04 | 400 | 50 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 4.42e-04 | 13 | 50 | 2 | GO:0072488 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 5.00e-04 | 418 | 50 | 6 | GO:0070371 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 5.02e-04 | 272 | 50 | 5 | GO:0006813 | |
| GeneOntologyCellularComponent | muscle myosin complex | 3.02e-10 | 16 | 51 | 5 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 3.62e-09 | 25 | 51 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 6.66e-09 | 28 | 51 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 3.20e-07 | 59 | 51 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | ankyrin-1 complex | 2.59e-04 | 10 | 51 | 2 | GO:0170014 | |
| GeneOntologyCellularComponent | Golgi membrane | 3.30e-04 | 721 | 51 | 8 | GO:0000139 | |
| GeneOntologyCellularComponent | myofibril | 5.27e-04 | 273 | 51 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | outer membrane | 6.00e-04 | 281 | 51 | 5 | GO:0019867 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.92e-04 | 290 | 51 | 5 | GO:0043292 | |
| HumanPheno | Anti-erythrocyte autoantibody positivity | 3.14e-05 | 3 | 17 | 2 | HP:6000388 | |
| HumanPheno | Positive direct antiglobulin test | 3.14e-05 | 3 | 17 | 2 | HP:0032366 | |
| Domain | Myosin_N | 3.29e-10 | 15 | 50 | 5 | IPR004009 | |
| Domain | Myosin_N | 3.29e-10 | 15 | 50 | 5 | PF02736 | |
| Domain | Myosin_tail_1 | 9.34e-10 | 18 | 50 | 5 | PF01576 | |
| Domain | Myosin_tail | 9.34e-10 | 18 | 50 | 5 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.27e-09 | 19 | 50 | 5 | IPR027401 | |
| Domain | - | 1.27e-09 | 19 | 50 | 5 | 4.10.270.10 | |
| Domain | MYOSIN_MOTOR | 5.26e-08 | 38 | 50 | 5 | PS51456 | |
| Domain | Myosin_head | 5.26e-08 | 38 | 50 | 5 | PF00063 | |
| Domain | Myosin_head_motor_dom | 5.26e-08 | 38 | 50 | 5 | IPR001609 | |
| Domain | MYSc | 5.26e-08 | 38 | 50 | 5 | SM00242 | |
| Domain | IQ | 1.28e-06 | 71 | 50 | 5 | PF00612 | |
| Domain | IQ | 2.46e-06 | 81 | 50 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.15e-06 | 90 | 50 | 5 | IPR000048 | |
| Domain | IQ | 4.87e-06 | 93 | 50 | 5 | PS50096 | |
| Domain | P-loop_NTPase | NDST3 MYH1 NDST1 MYH2 MYH3 MYH4 MYH13 SBNO1 CHST4 ZNFX1 ABCA7 | 1.16e-05 | 848 | 50 | 11 | IPR027417 |
| Domain | K_chnl_volt-dep_ELK | 2.10e-05 | 3 | 50 | 2 | IPR003950 | |
| Domain | HSNSD | 4.20e-05 | 4 | 50 | 2 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 4.20e-05 | 4 | 50 | 2 | IPR021930 | |
| Domain | Ammonium_transpt | 6.99e-05 | 5 | 50 | 2 | IPR001905 | |
| Domain | Ammonium_transp | 6.99e-05 | 5 | 50 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 6.99e-05 | 5 | 50 | 2 | IPR024041 | |
| Domain | RhesusRHD | 6.99e-05 | 5 | 50 | 2 | IPR002229 | |
| Domain | Sulfotransferase_dom | 1.21e-04 | 36 | 50 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 1.21e-04 | 36 | 50 | 3 | PF00685 | |
| Domain | - | 1.46e-04 | 7 | 50 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 1.46e-04 | 7 | 50 | 2 | IPR029020 | |
| Domain | PAS_9 | 3.12e-04 | 10 | 50 | 2 | PF13426 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 6.26e-04 | 14 | 50 | 2 | IPR003938 | |
| Domain | UDPGT | 1.43e-03 | 21 | 50 | 2 | PS00375 | |
| Domain | UDPGT | 1.43e-03 | 21 | 50 | 2 | PF00201 | |
| Domain | UDP_glucos_trans | 1.43e-03 | 21 | 50 | 2 | IPR002213 | |
| Domain | PAS_fold_3 | 1.71e-03 | 23 | 50 | 2 | IPR013655 | |
| Domain | PAS_3 | 1.71e-03 | 23 | 50 | 2 | PF08447 | |
| Domain | PAS-assoc_C | 1.87e-03 | 24 | 50 | 2 | IPR000700 | |
| Domain | PAC | 2.19e-03 | 26 | 50 | 2 | SM00086 | |
| Domain | PAC | 2.19e-03 | 26 | 50 | 2 | PS50113 | |
| Domain | PAC | 2.19e-03 | 26 | 50 | 2 | IPR001610 | |
| Domain | CNMP_BINDING_1 | 3.31e-03 | 32 | 50 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 3.31e-03 | 32 | 50 | 2 | PS00889 | |
| Domain | Ion_trans_dom | 3.52e-03 | 114 | 50 | 3 | IPR005821 | |
| Domain | Ion_trans | 3.52e-03 | 114 | 50 | 3 | PF00520 | |
| Domain | cNMP | 3.73e-03 | 34 | 50 | 2 | SM00100 | |
| Domain | PAS | 3.73e-03 | 34 | 50 | 2 | IPR000014 | |
| Domain | PAS | 3.73e-03 | 34 | 50 | 2 | PS50112 | |
| Domain | cNMP_binding | 3.73e-03 | 34 | 50 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 3.95e-03 | 35 | 50 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 3.95e-03 | 35 | 50 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 4.64e-03 | 38 | 50 | 2 | IPR018490 | |
| Domain | - | 7.32e-03 | 48 | 50 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 8.24e-03 | 51 | 50 | 2 | IPR014710 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.50e-06 | 70 | 40 | 5 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 3.37e-05 | 132 | 40 | 5 | M11355 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.59e-04 | 183 | 40 | 5 | M39588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 4.25e-04 | 11 | 40 | 2 | M47921 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.01e-04 | 55 | 40 | 3 | M14933 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.32e-14 | 6 | 51 | 5 | 10077619 | |
| Pubmed | 1.16e-13 | 7 | 51 | 5 | 35210422 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 10388558 | ||
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 2.05e-11 | 5 | 51 | 4 | 3829126 | |
| Pubmed | 6.14e-11 | 6 | 51 | 4 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 6.14e-11 | 6 | 51 | 4 | 10588881 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.43e-10 | 7 | 51 | 4 | 29758057 | |
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 16819597 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.34e-09 | 11 | 51 | 4 | 16024798 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 2.90e-09 | 13 | 51 | 4 | 8404542 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 2.97e-09 | 3 | 51 | 3 | 26059207 | |
| Pubmed | 4.06e-09 | 14 | 51 | 4 | 27184118 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 5.53e-09 | 15 | 51 | 4 | 24852826 | |
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 20357587 | ||
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 11023856 | ||
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.19e-08 | 4 | 51 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.19e-08 | 4 | 51 | 3 | 18417546 | |
| Pubmed | 2.94e-08 | 22 | 51 | 4 | 24301466 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 2.96e-08 | 5 | 51 | 3 | 30737693 | |
| Pubmed | Chronic multifocal osteomyelitis, a new recessive mutation on chromosome 18 of the mouse. | 2.96e-08 | 5 | 51 | 3 | 1686018 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 6879174 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.96e-08 | 5 | 51 | 3 | 12919077 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 5.92e-08 | 6 | 51 | 3 | 17559643 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 1.63e-07 | 33 | 51 | 4 | 32094117 | |
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 26993635 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 3864153 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 36200826 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 33667029 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 1.65e-07 | 8 | 51 | 3 | 14667415 | |
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 31960486 | ||
| Pubmed | 3.25e-07 | 39 | 51 | 4 | 38690566 | ||
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 3.54e-07 | 10 | 51 | 3 | 8950513 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 4.86e-07 | 11 | 51 | 3 | 38303699 | |
| Pubmed | 4.86e-07 | 11 | 51 | 3 | 18310078 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 4.86e-07 | 11 | 51 | 3 | 29168801 | |
| Pubmed | 4.86e-07 | 11 | 51 | 3 | 8136524 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 6.39e-07 | 46 | 51 | 4 | 28827394 | |
| Pubmed | Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. | 8.41e-07 | 13 | 51 | 3 | 10694423 | |
| Pubmed | 8.41e-07 | 13 | 51 | 3 | 8948582 | ||
| Pubmed | Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. | 8.41e-07 | 13 | 51 | 3 | 7797078 | |
| Pubmed | 1.07e-06 | 14 | 51 | 3 | 24938781 | ||
| Pubmed | 1.07e-06 | 14 | 51 | 3 | 33742095 | ||
| Pubmed | 1.64e-06 | 58 | 51 | 4 | 21884692 | ||
| Pubmed | 1.64e-06 | 16 | 51 | 3 | 16494860 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 1.64e-06 | 16 | 51 | 3 | 19922871 | |
| Pubmed | 1.99e-06 | 17 | 51 | 3 | 16124007 | ||
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 1.99e-06 | 17 | 51 | 3 | 22351927 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8188244 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11724987 | ||
| Pubmed | DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. | 2.11e-06 | 2 | 51 | 2 | 17900276 | |
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 2.11e-06 | 2 | 51 | 2 | 9585413 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32697929 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10627438 | ||
| Pubmed | Polymorphisms in the promoter regions of RHD and RHCE genes in the Chinese Han population. | 2.11e-06 | 2 | 51 | 2 | 37823181 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30089826 | ||
| Pubmed | Review: the molecular basis of the Rh blood group phenotypes. | 2.11e-06 | 2 | 51 | 2 | 15373666 | |
| Pubmed | Intron 4 of the RH Gene in Han Chinese, Tibetan, and Mongol Populations. | 2.11e-06 | 2 | 51 | 2 | 26579938 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34968422 | ||
| Pubmed | Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia. | 2.11e-06 | 2 | 51 | 2 | 29193104 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 1898705 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11161244 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 16575183 | ||
| Pubmed | RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2). | 2.11e-06 | 2 | 51 | 2 | 25857637 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22738288 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24760207 | ||
| Pubmed | Multiple Rh messenger RNA isoforms are produced by alternative splicing. | 2.11e-06 | 2 | 51 | 2 | 1379850 | |
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 2.11e-06 | 2 | 51 | 2 | 7545970 | |
| Pubmed | RHCE variants inherited with altered RHD alleles in Brazilian blood donors. | 2.11e-06 | 2 | 51 | 2 | 27111588 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10329015 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8822955 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8808597 | ||
| Pubmed | Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. | 2.11e-06 | 2 | 51 | 2 | 12201845 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.11e-06 | 2 | 51 | 2 | 9382868 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11150240 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 2.11e-06 | 2 | 51 | 2 | 22337492 | |
| Pubmed | Variant RH alleles and Rh immunisation in patients with sickle cell disease. | 2.11e-06 | 2 | 51 | 2 | 24960646 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22441538 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21679149 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23772606 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30418133 | ||
| Pubmed | A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. | 2.11e-06 | 2 | 51 | 2 | 23550903 | |
| Pubmed | Molecular cloning and primary structure of the human blood group RhD polypeptide. | 2.11e-06 | 2 | 51 | 2 | 1438298 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 3135863 | ||
| Pubmed | Molecular background of D(C)(e) haplotypes within the white population. | 2.11e-06 | 2 | 51 | 2 | 12084172 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21102503 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10924335 | ||
| Pubmed | Sequences and evolution of mammalian RH gene transcripts and proteins. | 2.11e-06 | 2 | 51 | 2 | 9811965 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12857961 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20233350 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12393640 | ||
| Pubmed | Molecular genetic basis of the human Rhesus blood group system. | 2.11e-06 | 2 | 51 | 2 | 8220426 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8900235 | ||
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 2.11e-06 | 2 | 51 | 2 | 11551968 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23742316 | ||
| Pubmed | Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system. | 2.11e-06 | 2 | 51 | 2 | 7916743 | |
| Pubmed | A comprehensive survey of both RHD and RHCE allele frequencies in sub-Saharan Africa. | 2.11e-06 | 2 | 51 | 2 | 24033223 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22690701 | ||
| Interaction | ASAH2 interactions | 2.69e-07 | 6 | 49 | 3 | int:ASAH2 | |
| Interaction | TSPAN33 interactions | 5.10e-07 | 65 | 49 | 5 | int:TSPAN33 | |
| Interaction | RSPH6A interactions | 1.36e-06 | 34 | 49 | 4 | int:RSPH6A | |
| Interaction | STK4 interactions | 2.32e-06 | 159 | 49 | 6 | int:STK4 | |
| Interaction | TMEM260 interactions | 3.80e-06 | 13 | 49 | 3 | int:TMEM260 | |
| Interaction | PRKAG2 interactions | 2.24e-05 | 68 | 49 | 4 | int:PRKAG2 | |
| Interaction | KCNH8 interactions | 3.46e-05 | 4 | 49 | 2 | int:KCNH8 | |
| Interaction | UGT2B28 interactions | 8.63e-05 | 6 | 49 | 2 | int:UGT2B28 | |
| Interaction | LATS1 interactions | 8.77e-05 | 440 | 49 | 7 | int:LATS1 | |
| Interaction | ABTB2 interactions | 1.06e-04 | 101 | 49 | 4 | int:ABTB2 | |
| Interaction | MAP3K19 interactions | 1.21e-04 | 7 | 49 | 2 | int:MAP3K19 | |
| Interaction | UGT2B11 interactions | 1.21e-04 | 7 | 49 | 2 | int:UGT2B11 | |
| Interaction | AURKC interactions | 1.56e-04 | 43 | 49 | 3 | int:AURKC | |
| Interaction | NDST4 interactions | 1.61e-04 | 8 | 49 | 2 | int:NDST4 | |
| Interaction | CDK3 interactions | 1.69e-04 | 114 | 49 | 4 | int:CDK3 | |
| Interaction | ABCG4 interactions | 2.06e-04 | 9 | 49 | 2 | int:ABCG4 | |
| Cytoband | 17p13.1 | 9.44e-06 | 118 | 51 | 4 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 4.18e-05 | 346 | 51 | 5 | chr17p13 | |
| Cytoband | 12p13.3 | 5.16e-04 | 30 | 51 | 2 | 12p13.3 | |
| Cytoband | 4q13.2 | 5.51e-04 | 31 | 51 | 2 | 4q13.2 | |
| Cytoband | 1p36.11 | 2.63e-03 | 68 | 51 | 2 | 1p36.11 | |
| Cytoband | 2q11.2 | 2.94e-03 | 72 | 51 | 2 | 2q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q33 | 7.69e-03 | 118 | 51 | 2 | chr5q33 | |
| GeneFamily | Myosin heavy chains | 8.02e-11 | 15 | 37 | 5 | 1098 | |
| GeneFamily | Sulfotransferases, membrane bound | 5.84e-05 | 37 | 37 | 3 | 763 | |
| GeneFamily | UDP glucuronosyltransferases | 1.94e-03 | 32 | 37 | 2 | 363 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 2.59e-03 | 37 | 37 | 2 | 454 | |
| GeneFamily | Potassium voltage-gated channels | 3.03e-03 | 40 | 37 | 2 | 274 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.32e-03 | 394 | 37 | 4 | 471 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 7.73e-06 | 20 | 51 | 3 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 9.00e-06 | 21 | 51 | 3 | MM1102 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN | 2.42e-05 | 177 | 51 | 5 | M8666 | |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_DN | 4.14e-05 | 198 | 51 | 5 | M4426 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 164 | 51 | 5 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.86e-06 | 77 | 51 | 4 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-06 | 184 | 51 | 5 | ca940a4f4970285ed284d5517d142abab0682044 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-06 | 186 | 51 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.69e-06 | 192 | 51 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | Parenchymal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 133 | 51 | 4 | 8819fd897b97812355e1709fcc42754522d5fb27 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 133 | 51 | 4 | b4e68a9a223e5188f1a00c7dc9bb2d675cde1d40 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.49e-05 | 148 | 51 | 4 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.38e-05 | 160 | 51 | 4 | fe5fb0e7a79862f63529721f0a82f4f6d231d3ca | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.38e-05 | 160 | 51 | 4 | 7d34159363d274019e14549d1186c629ce990691 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.55e-05 | 162 | 51 | 4 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 163 | 51 | 4 | 8509b87748ec460992ae6cedbb155e1c6f6e2e48 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 163 | 51 | 4 | e04de78a52cc886623689a913f7852200a77605b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.18e-05 | 169 | 51 | 4 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 4.79e-05 | 175 | 51 | 4 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 4.79e-05 | 175 | 51 | 4 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.95e-05 | 62 | 51 | 3 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.95e-05 | 62 | 51 | 3 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Late_pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.12e-05 | 178 | 51 | 4 | 4e28a8bd5a603518bfe993712ab785308691b5ff | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.46e-05 | 181 | 51 | 4 | 6df40f86c569b6ecfc3137a68d1355b012dbf6bf | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-05 | 182 | 51 | 4 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-05 | 182 | 51 | 4 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.70e-05 | 65 | 51 | 3 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.70e-05 | 65 | 51 | 3 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.07e-05 | 186 | 51 | 4 | f352c63666273defea3e57ba3a3bfad52c4ea65b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.07e-05 | 186 | 51 | 4 | e2d265003aaea1acaf618d3f102c9933c19102e6 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.20e-05 | 187 | 51 | 4 | b5cb8760fa667c237902d50a78dea4cb1babd607 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 7.29e-05 | 195 | 51 | 4 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 195 | 51 | 4 | 027075e9c62b5754a014a9d1393e1b0f5ae42e41 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 195 | 51 | 4 | 1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.44e-05 | 196 | 51 | 4 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.44e-05 | 196 | 51 | 4 | 0ebf7e5a9281ec1f33dccd1f8895afd513591b91 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.44e-05 | 196 | 51 | 4 | bd482b7df2993d87c0997a40c4cbd34ba07910cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.58e-05 | 197 | 51 | 4 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.58e-05 | 197 | 51 | 4 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.73e-05 | 198 | 51 | 4 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-05 | 199 | 51 | 4 | a4785c1921a3de18a9190e4d674ede6a90f80004 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 7.89e-05 | 199 | 51 | 4 | 80c8641cfd84436eadf2234f1313749e2f73331f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 8.04e-05 | 200 | 51 | 4 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | Caecum-Mast_cell|Caecum / Region, Cell class and subclass | 8.04e-05 | 200 | 51 | 4 | 8791d0b3d883e7a747a23d21118817f5be4013b6 | |
| ToppCell | Caecum-(7)_Mast_cell-(70)_Mast|Caecum / shred on region, Cell_type, and subtype | 8.04e-05 | 200 | 51 | 4 | 9974285c28a633a010c4f24d035ad3685705e881 | |
| ToppCell | Caecum-Mast_cell-Mast|Caecum / Region, Cell class and subclass | 8.04e-05 | 200 | 51 | 4 | 168426e8296697d05684d71989c4eb5bb2a0489f | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Chat_(Habenular_cholinergic_cells)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 82 | 51 | 3 | 51dd9ab3ddb26d3d3395d0c1a156a12a86caf89b | |
| Drug | fast white | 3.68e-08 | 42 | 51 | 5 | CID000024008 | |
| Drug | AC1N9ZZC | 4.06e-08 | 149 | 51 | 7 | CID004369374 | |
| Drug | formycin triphosphate | 1.00e-07 | 51 | 51 | 5 | CID000122274 | |
| Drug | purealin | 1.93e-07 | 58 | 51 | 5 | CID006419303 | |
| Drug | NSC9700 | 5.15e-07 | 578 | 51 | 10 | CID000005408 | |
| Drug | clenbuterol | 7.57e-07 | 142 | 51 | 6 | CID000002783 | |
| Drug | SM-2 | 1.48e-06 | 87 | 51 | 5 | CID000486033 | |
| Drug | carvedilol | 1.58e-06 | 161 | 51 | 6 | CID000002585 | |
| Drug | S-(-)-Etomoxir | 2.96e-06 | 100 | 51 | 5 | CID000060765 | |
| Drug | nifedipine | 3.65e-06 | 415 | 51 | 8 | CID000004485 | |
| Drug | K-Cl | 4.14e-06 | 567 | 51 | 9 | CID000004873 | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 4.50e-06 | 193 | 51 | 6 | 5273_DN | |
| Drug | blebbistatin | 6.13e-06 | 116 | 51 | 5 | CID003476986 | |
| Drug | B0683 | 6.40e-06 | 117 | 51 | 5 | CID006398969 | |
| Drug | oxovanadium | 7.24e-06 | 120 | 51 | 5 | CID000024411 | |
| Drug | 2bq7 | 8.16e-06 | 123 | 51 | 5 | CID006540267 | |
| Drug | wartmannin | 1.06e-05 | 811 | 51 | 10 | CID000005691 | |
| Drug | AC1LADJ6 | 1.07e-05 | 130 | 51 | 5 | CID000486032 | |
| Drug | Spermine | 1.21e-05 | 63 | 51 | 4 | ctd:D013096 | |
| Drug | AC1NRBPQ | 1.38e-05 | 137 | 51 | 5 | CID005288569 | |
| Drug | candesartan cilexetil | 1.81e-05 | 145 | 51 | 5 | CID000002540 | |
| Drug | carbachol | 1.95e-05 | 688 | 51 | 9 | CID000002551 | |
| Drug | D-triiodothyronine | 3.36e-05 | 409 | 51 | 7 | CID000000861 | |
| Drug | LY294002 | 3.75e-05 | 748 | 51 | 9 | CID000003973 | |
| Drug | oxyfedrine | 4.90e-05 | 5 | 51 | 2 | CID000027454 | |
| Drug | NSC226080 | 5.30e-05 | 782 | 51 | 9 | CID000005040 | |
| Drug | SN-38 | 5.67e-05 | 184 | 51 | 5 | CID000104842 | |
| Drug | Pertussis Toxin | 5.87e-05 | 94 | 51 | 4 | ctd:D037342 | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 6.61e-05 | 190 | 51 | 5 | 2299_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.94e-05 | 192 | 51 | 5 | 5567_UP | |
| Drug | creatine | 7.11e-05 | 193 | 51 | 5 | CID000000586 | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 7.29e-05 | 194 | 51 | 5 | 3213_UP | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 7406_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 4980_UP | |
| Drug | 4-chloroaniline | 8.82e-05 | 202 | 51 | 5 | CID000007812 | |
| Drug | verapamil | 1.05e-04 | 490 | 51 | 7 | CID000002520 | |
| Drug | testosterone glucuronide | 1.06e-04 | 41 | 51 | 3 | CID000108192 | |
| Drug | N-ethylmaleimide | 1.36e-04 | 511 | 51 | 7 | CID000004362 | |
| Drug | eye gene | 1.69e-04 | 369 | 51 | 6 | CID000004782 | |
| Drug | salicylamide | 1.71e-04 | 48 | 51 | 3 | CID000005147 | |
| Drug | UDP - Na | 1.79e-04 | 235 | 51 | 5 | CID000001158 | |
| Drug | 4-methylumbelliferone | 2.18e-04 | 132 | 51 | 4 | CID003364573 | |
| Drug | 2-aminophenol | 2.19e-04 | 10 | 51 | 2 | ctd:C027667 | |
| Drug | nylidrin | 2.19e-04 | 10 | 51 | 2 | CID000004567 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 8.03e-12 | 12 | 49 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 8.03e-12 | 12 | 49 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.30e-11 | 13 | 49 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.04e-11 | 15 | 49 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.18e-09 | 80 | 49 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.66e-08 | 48 | 49 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.23e-07 | 71 | 49 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Anemia, Hemolytic, Congenital | 2.70e-06 | 2 | 49 | 2 | C0002881 | |
| Disease | phosphatidylcholine 36:4 measurement | 3.45e-06 | 18 | 49 | 3 | EFO_0010382 | |
| Disease | Rh Deficiency Syndrome | 8.10e-06 | 3 | 49 | 2 | C0272052 | |
| Disease | Rh-Null, Regulator Type | 8.10e-06 | 3 | 49 | 2 | C1849387 | |
| Disease | Hypokalemia | 5.64e-05 | 7 | 49 | 2 | C0020621 | |
| Disease | asthma (is_implicated_in) | 1.36e-04 | 157 | 49 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | Lung diseases | 3.00e-04 | 78 | 49 | 3 | C0024115 | |
| Disease | sinusitis (is_marker_for) | 4.06e-04 | 18 | 49 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 5.56e-04 | 21 | 49 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | lung disease (is_implicated_in) | 6.11e-04 | 22 | 49 | 2 | DOID:850 (is_implicated_in) | |
| Disease | azoospermia (implicated_via_orthology) | 9.23e-04 | 27 | 49 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 1.07e-03 | 29 | 49 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | rhinitis (is_implicated_in) | 1.14e-03 | 30 | 49 | 2 | DOID:4483 (is_implicated_in) | |
| Disease | Bipolar Disorder | 1.15e-03 | 477 | 49 | 5 | C0005586 | |
| Disease | pulmonary sarcoidosis (is_marker_for) | 1.30e-03 | 32 | 49 | 2 | DOID:13406 (is_marker_for) | |
| Disease | phosphatidylcholine 38:5 measurement | 1.38e-03 | 33 | 49 | 2 | EFO_0010387 | |
| Disease | lung disease (biomarker_via_orthology) | 1.55e-03 | 35 | 49 | 2 | DOID:850 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAHILMKMWTFGNFW | 91 | P07550 | |
| MKMWTFGNFWCEFWT | 96 | P07550 | |
| WMMDNNFSHHWKGMF | 16 | Q86U02 | |
| GHFFRFWMKWLLRQM | 11 | Q8IZ81 | |
| IFMALWATMFLENWK | 446 | Q9NQ90 | |
| FFMKMRIEHIWLQKW | 256 | Q8IUH2 | |
| MAFWTQLMLLLWKNF | 1 | Q8IZY2 | |
| SVDEFWWFPHMWSHM | 371 | O95803 | |
| WMMVHFDCTGFWVKD | 306 | P19113 | |
| VAIWMFVFHMKPWSG | 71 | P47900 | |
| KLWWPHSEAMIAFLM | 321 | P51606 | |
| HQVIQWFWKAVLMMD | 1221 | P46934 | |
| MWIAMFSYLMVWWAH | 946 | O60721 | |
| WNFKIMFHQFEMIWA | 521 | Q2LD37 | |
| FGRWMFHTTQMIKAW | 181 | Q96BY2 | |
| AATMMWFEKLHVWLL | 1341 | Q96RV3 | |
| MEGFKNWEFMTIHCW | 546 | Q92824 | |
| SFMNVKHWPWMKLFF | 826 | Q9UKX2 | |
| VKEFWWFPHMWSHMQ | 381 | P52848 | |
| MSVFALLAHWMACIW | 366 | Q9UQ05 | |
| AFHNWKWLLMRNMVC | 41 | Q6UWN0 | |
| LQYSWMFLMAFALGW | 596 | P04150 | |
| NVRAFMNVKHWPWMK | 821 | P12882 | |
| MKLWVSALLMAWFGV | 1 | O15460 | |
| WFHILGMMMFIWSSA | 201 | Q9H8P0 | |
| WFRNMMGNAWALVAH | 321 | Q6GPH6 | |
| LAINAFNLSWMAAMW | 211 | Q8N0S6 | |
| WMDEHKHMVYLAWNI | 436 | Q9NY28 | |
| FESWMHHWLLFEMSR | 181 | P04233 | |
| FTDHMLMVEWNDKGW | 61 | O15382 | |
| KFVMGQLKGFSAHWW | 201 | Q9Y5Q0 | |
| KKSMWGQFWSAHQRF | 586 | A3KN83 | |
| KVFEHNMWDHMQWSK | 41 | Q9H825 | |
| WFFTWVGLEMNMLAF | 26 | P03891 | |
| GWAWMMVLSSFFVHI | 31 | Q7RTX9 | |
| NIRAFMNVKHWPWMK | 821 | Q9Y623 | |
| SFMNVKHWPWMKLFF | 821 | P11055 | |
| ESLFWKLNQWLMIHM | 186 | Q9UBY8 | |
| LMEPAWHVWMTFKQS | 71 | Q8NCG5 | |
| WIKLMNWQHSTMYLF | 81 | Q96B21 | |
| WMFSIHLPSKMKVWQ | 116 | Q8TC36 | |
| SLSAMLGALFLWMFW | 206 | Q02161 | |
| SLSAMLGALFLWMFW | 206 | P18577 | |
| KLGWMWVFYFFILMT | 451 | Q8NCC5 | |
| NFWMVWSEAMAHGCF | 111 | Q5TYX0 | |
| NIRSFMNVKHWPWMN | 821 | Q9UKX3 | |
| MNVKHWPWMNLFFKI | 826 | Q9UKX3 | |
| VLVWAAEYSHWMNMK | 26 | O75310 | |
| WICFQHWKHSMMLEW | 771 | Q9P2E3 | |
| MFWMFLNSVFHFMWV | 531 | Q8IUH5 | |
| IHDWWNLMDFAMNSL | 431 | Q9UL62 | |
| VLVWTGEYSHWMNMK | 26 | Q9BY64 | |
| RFHGLWYMKMMWAWL | 611 | O60603 | |
| VQMHDVLVKAWAMWG | 3146 | Q9Y4A5 | |
| SMFALLAHWMACIWY | 361 | Q96L42 | |
| LAHWMACIWYVIGKM | 366 | Q96L42 |